Fig. 4From: EAACI Task force Clinical epidemiology of anaphylaxis: experts’ perspective on the use of adrenaline autoinjectors in EuropeProportions of experts being influenced by regulatory, reimbursement and availability aspects in their decision regarding number of AAIs per one patientBack to article page